Searched for
PHARMA COMPANY REGULATIONS
Drugmakers tap China AI app boom to reach doctors as crackdown upends marketingAs scrutiny intensifies, Chinese pharmaceutical companies are shifting gears toward digital marketing initiatives. Traditional face-to-face...- Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
- Over 1,300 anti-cancer drugs to get cheaperIndia's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative a...
- Cancer drug prices revised from today; patients may save Rs 3,540 crore annuallyThe government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit tra...
- Govt plans instant ban on manufacturing of drugs failing key quality testsPharma companies could have their drug licenses suspended immediately if quality tests indicate failure. The health ministry's proposed cha...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets extended their rally, with Sensex gaining 384 points to 77,301 and Nifty rising 150 points to 23,961, marking two-month high...
- India leads on non-animal testing and its draft lab animal rules threaten to undo thatIndia's draft Prevention of Cruelty to Animals Rules 2026 proposes significant changes to animal research regulations and oversight. It all...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- Beyond tech: Kotak MF’s Shibani Kurian on India’s next innovation-led winnersInnovation-led investment opportunities in India are extending well beyond technology, with healthcare, auto components and industrials eme...
- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Why did market rally today? Sensex soars 1,233 pts, Nifty ends above 23,400. 7 factors behind Rs 8 lakh crore gainsOn Monday, a remarkable surge in the Indian stock market was observed, with the Sensex soaring by 1,233 points. This uplift was driven by p...
- Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: ReportIndian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...
- These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsHere’s one thing that is worth clarifying, because it is in the headlines. Large global technology companies have been announcing heavy spe...
- Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...
- Stocks in news: Jio Platforms, RIL, Infosys, L&T, Tata Capital, Waaree Energies and Vedanta IronIndian benchmark indices saw a volatile session amid the Nifty and Bank Nifty monthly expiry. Stocks like Jio Platforms made headlines foll...
- Stocks in news: Infosys, Kotak Mahindra Bank, YES Bank, Raymond, BPCL, Coforge and Senco GoldIndian equity markets have faced a decline for four consecutive sessions, with the Nifty falling significantly. Various factors, including ...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
- Fertiliser stocks: Combination of strong headwinds and structural repair. Who will win? 9 stocks, 4 with upside potential of up to 31%For the better part of a decade now, every time this critical sector has run into trouble, the government has stepped in. The clean-up bega...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
Load More
